HPV vaccine hesitancy among parents of female adolescents: a pre-post interventional study

Sara Palmeri; Gianmarco Ventura; Claudio Costantino; Alessandra Casuccio; Fanny Pojero; Francesco Vitale

HPV vaccine hesitancy among parents of female adolescents: a pre-post interventional study

Sara Palmeri, Gianmarco Ventura, Claudio Costantino, Alessandra Casuccio, Fanny Pojero, Francesco Vitale

Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”

Risultato della ricerca: Article › peer review

12 Citazioni (Scopus)

Abstract

Human papillomavirus (HPV) is the most common sexuallytransmitted infection in female adolescents. The highestinfection rate is found among individuals aged 15-24 years,and the HPV vaccine represents an opportunity to reduce theburden of cervical cancer caused by HPV types 16 and 18. TheWorld Health Organization has defined girls aged 9e13 years asthe priority target for HPV vaccination. In Italy, in accordancewith international public health guidelines, HPV vaccinationwasfree and actively offered to all girls during their 12th year oflife (from the completion of 11 years until the age of 12 years)between 2007 and 2008, establishing a target vaccinationcoverage of 95% within 5 years of the start of the campaign.

Lingua originale	English
pagine (da-a)	84-86
Numero di pagine	3
Rivista	Public Health
Volume	150
Stato di pubblicazione	Published - 2017

All Science Journal Classification (ASJC) codes

Public Health, Environmental and Occupational Health

Accesso al documento

Fingerprint Entra nei temi di ricerca di 'HPV vaccine hesitancy among parents of female adolescents: a pre-post interventional study'. Insieme formano una fingerprint unica.

Cita questo

@article{fee241e350a948dba77d01ababa83a11,

title = "HPV vaccine hesitancy among parents of female adolescents: a pre-post interventional study",

abstract = "Human papillomavirus (HPV) is the most common sexuallytransmitted infection in female adolescents. The highestinfection rate is found among individuals aged 15-24 years,and the HPV vaccine represents an opportunity to reduce theburden of cervical cancer caused by HPV types 16 and 18. TheWorld Health Organization has defined girls aged 9e13 years asthe priority target for HPV vaccination. In Italy, in accordancewith international public health guidelines, HPV vaccinationwasfree and actively offered to all girls during their 12th year oflife (from the completion of 11 years until the age of 12 years)between 2007 and 2008, establishing a target vaccinationcoverage of 95% within 5 years of the start of the campaign.",

author = "Sara Palmeri and Gianmarco Ventura and Claudio Costantino and Alessandra Casuccio and Fanny Pojero and Francesco Vitale",

year = "2017",

language = "English",

volume = "150",

pages = "84--86",

journal = "Public Health",

issn = "0033-3506",

publisher = "Elsevier",

}

TY - JOUR

T1 - HPV vaccine hesitancy among parents of female adolescents: a pre-post interventional study

AU - Palmeri, Sara

AU - Ventura, Gianmarco

AU - Costantino, Claudio

AU - Casuccio, Alessandra

AU - Pojero, Fanny

AU - Vitale, Francesco

PY - 2017

Y1 - 2017

N2 - Human papillomavirus (HPV) is the most common sexuallytransmitted infection in female adolescents. The highestinfection rate is found among individuals aged 15-24 years,and the HPV vaccine represents an opportunity to reduce theburden of cervical cancer caused by HPV types 16 and 18. TheWorld Health Organization has defined girls aged 9e13 years asthe priority target for HPV vaccination. In Italy, in accordancewith international public health guidelines, HPV vaccinationwasfree and actively offered to all girls during their 12th year oflife (from the completion of 11 years until the age of 12 years)between 2007 and 2008, establishing a target vaccinationcoverage of 95% within 5 years of the start of the campaign.

AB - Human papillomavirus (HPV) is the most common sexuallytransmitted infection in female adolescents. The highestinfection rate is found among individuals aged 15-24 years,and the HPV vaccine represents an opportunity to reduce theburden of cervical cancer caused by HPV types 16 and 18. TheWorld Health Organization has defined girls aged 9e13 years asthe priority target for HPV vaccination. In Italy, in accordancewith international public health guidelines, HPV vaccinationwasfree and actively offered to all girls during their 12th year oflife (from the completion of 11 years until the age of 12 years)between 2007 and 2008, establishing a target vaccinationcoverage of 95% within 5 years of the start of the campaign.

UR - http://hdl.handle.net/10447/265053

UR - http://www.elsevier.com/inca/publications/store/6/4/5/7/2/7/645727.pub.htt

M3 - Article

VL - 150

SP - 84

EP - 86

JO - Public Health

JF - Public Health

SN - 0033-3506

ER -